PUBLIC COMPANY
saveTisento Therapeutics Inc
updated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Phase 2b Study of Zagociguat in Patients With MELAS
- phase2An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)
- phase2A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology
- phase2Phase 2a Study of IW-6463 in Adults Diagnosed With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)
- phase1IW-6463 Safety Study in Healthy Elderly Subjects
- phase1A Study of IW-6463 in Healthy Volunteers
- phase1Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that